臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wu s g"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 81-130 of 224 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-12-02T02:33:29Z	EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway	Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:26Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Pan-Chyr Yang; Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:23Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.; Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:21Z	Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma	Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:19Z	The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition	Wu S.-G.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:14Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.; PAN-CHYR YANG et al.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Pan-Chyr Yang; Shih J.-Y.
臺大學術典藏	2020-08-18T07:28:24Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Yang J.C.-H.; YU-FEN WANG; Lin Y.-T.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-08-13T06:34:00Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.
臺大學術典藏	2020-08-13T06:34:00Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; JIN-YUAN SHIH; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:56Z	Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation	Kuo Y.-W.;Wu S.-G.;Ho C.-C.;Jin-Yuan Shih; Kuo Y.-W.; Wu S.-G.; Ho C.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:54Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.
臺大學術典藏	2020-08-13T06:33:53Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Chang Y.-L.; JIN-YUAN SHIH; Yang P.-C.; Hsu Y.-C.; Lee J.-H.; Wu S.-G.;Yang C.-H.;Yu C.-J.;Lee J.-H.;Hsu Y.-C.;Chang Y.-L.;Jin-Yuan Shih;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:53Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:52Z	Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction	Lee Y.-C.; Tsai M.-F.; Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:50Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Tsai M.-F.; Yu C.-J.; Chen Y.-H.; JIN-YUAN SHIH; Chang Y.-L.; Kuo Y.-W.; Wu S.-G.; Wu S.-G.;Kuo Y.-W.;Chang Y.-L.;Jin-Yuan Shih;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:50Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	JIN-YUAN SHIH; Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:47Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:46Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; JIN-YUAN SHIH; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:46Z	Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas	Lin C.-H.; Cheng A.-L.; Wu S.-G.; JIN-YUAN SHIH; Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.
臺大學術典藏	2020-08-13T06:33:45Z	Brain Metastasis of Patients with Lung Adenocarcinoma: Epidermal Growth Factor Receptor Mutations and Response to Whole-Brain Radiation Therapy	Wu S.-G.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:45Z	Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case	Gow C.-H.; Wu S.-G.; Chang Y.-L.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:44Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	JIN-YUAN SHIH; Yang J.C.-H.; Yu S.-L.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; Tsai T.-H.; Chen H.-Y.
臺大學術典藏	2020-08-13T06:33:41Z	EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway	Yang P.-C.; Hsu Y.-C.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:39Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:35Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Jin-Yuan Shih; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; JIN-YUAN SHIH; Chang T.-H.; Tsai M.-F.; Gow C.-H.
臺大學術典藏	2020-08-13T06:33:32Z	Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer	Wu S.-G.;Jin-Yuan Shih; Wu S.-G.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:30Z	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion	JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Wu S.-G.;Liu Y.-N.;Yu C.-J.;Yang J.C.-H.;Jin-Yuan Shih
臺大學術典藏	2020-08-13T06:33:29Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Hsu C.-L.; Liu Y.-N.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Jin-Yuan Shih; Chang Y.-L.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:26Z	Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer	Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Chang Y.-L.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Chang Y.-L.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:23Z	MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process	Wang H.-Y.; Liu Y.-N.; Wu S.-G.; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; JIN-YUAN SHIH; Wang H.-Y.;Liu Y.-N.;Wu S.-G.;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Jin-Yuan Shih
臺大學術典藏	2020-08-13T06:33:22Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	JIN-YUAN SHIH; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; Lin Y.-T.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Jin-Yuan Shih
臺大學術典藏	2020-08-12T06:35:14Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Shih J.-Y.; Yang P.-C.; Wei P.-F.; Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Chong-Jen Yu;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU
臺大學術典藏	2020-08-12T06:35:08Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Lee Y.-C.; CHONG-JEN YU; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; Chang Y.-L.; Hu F.-C.; Wu S.-G.;Hu F.-C.;Chang Y.-L.;Lee Y.-C.;Chong-Jen Yu;Chang Y.-C.;Wu J.-Y.;Shih J.-Y.;Yang P.-C.; Wu S.-G.
臺大學術典藏	2020-08-12T06:35:07Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.;Chong-Jen Yu;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; CHONG-JEN YU; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-08-12T06:34:10Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Chong-Jen Yu;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; Wu S.-G.
臺大學術典藏	2020-08-12T03:39:15Z	Treatment outcome of patients with isoniazid mono-resistant tuberculosis	Wu S.-G.; Chen Y.-T.; Jung-Yien Chien;Chen Y.-T.;Wu S.-G.;Lee J.-J.;Wang J.-Y.;Yu C.-J.; JUNG-YIEN CHIEN; Lee J.-J.; Wang J.-Y.; Yu C.-J.
臺大學術典藏	2020-07-21T06:46:33Z	Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation	Kuo Y.-W.; Wu S.-G.; CHAO-CHI HO; Shih J.-Y.
臺大學術典藏	2020-07-21T06:25:20Z	Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis	Wu S.-G.;Tzu-Hsiu Tsai;Wu S.-J.; Wu S.-G.; TZU-HSIU TSAI; Wu S.-J.
臺大學術典藏	2020-07-21T06:25:19Z	RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer	TZU-HSIU TSAI; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-07-21T06:25:19Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Yang P.-C.; Shih J.-Y.; Yu C.-J.; Yang C.-H.; TZU-HSIU TSAI; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.
臺大學術典藏	2020-07-21T06:25:18Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tzu-Hsiu Tsai;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2020-07-21T06:25:17Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Tzu-Hsiu Tsai;Wu S.-G.;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; TZU-HSIU TSAI; Wu S.-G.; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y.
臺大學術典藏	2020-07-21T06:25:17Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H.
臺大學術典藏	2020-07-21T06:25:15Z	Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer	Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tzu-Hsiu Tsai;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; TZU-HSIU TSAI; Gow C.-H.; Chang Y.-L.; Shih J.-Y.
臺大學術典藏	2020-07-21T06:25:14Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	TZU-HSIU TSAI; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.; Lin Y.-T.; Lin Y.-T.;Tzu-Hsiu Tsai;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Shih J.-Y.
臺大學術典藏	2020-07-21T06:09:14Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.;Yu C.-J.;Tsai M.-F.;Wei-Yu Liao;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; WEI-YU LIAO; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-06-30T08:10:09Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Chang T.-H. ;Tsai M.-F. ;Kang-Yi Su ;Wu S.-G. ;Huang C.-P. ;Yu S.-L. ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; KANG-YI SU; Wu S.-G.; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-06-17T03:01:51Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Chang T.-H. ;Tsai M.-F. ;Su K.-Y. ;Wu S.-G. ;Huang C.-P. ;Sung-Liang Yu ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.; Huang C.-P.; SUNG-LIANG YU; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-06-17T03:01:31Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Sung-Liang Yu;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; SUNG-LIANG YU; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-05-26T09:27:23Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C.

Showing items 81-130 of 224 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51345741 Online Users : 664 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library